Segall Bryant & Hamill LLC cut its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 3.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 291,309 shares of the company's stock after selling 10,361 shares during the quarter. Segall Bryant & Hamill LLC owned 0.17% of Option Care Health worth $6,758,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also added to or reduced their stakes in the stock. UMB Bank n.a. raised its stake in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after acquiring an additional 346 shares during the last quarter. Signaturefd LLC lifted its holdings in Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after buying an additional 1,005 shares during the period. Quarry LP grew its position in shares of Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company's stock valued at $107,000 after buying an additional 2,628 shares during the last quarter. Blue Trust Inc. increased its stake in shares of Option Care Health by 16.9% in the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after buying an additional 681 shares during the period. Finally, Venturi Wealth Management LLC raised its position in shares of Option Care Health by 2,621.3% during the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock worth $110,000 after acquiring an additional 4,561 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Option Care Health
In related news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.64% of the stock is owned by insiders.
Option Care Health Stock Down 1.3 %
OPCH stock traded down $0.47 during midday trading on Friday, reaching $34.73. 1,378,809 shares of the company's stock traded hands, compared to its average volume of 1,713,822. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The firm's fifty day moving average price is $32.47 and its 200-day moving average price is $28.41. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a market cap of $5.70 billion, a price-to-earnings ratio of 29.18, a P/E/G ratio of 2.30 and a beta of 1.33.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on OPCH. JMP Securities reissued a "market outperform" rating and set a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and upped their price target for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. JPMorgan Chase & Co. lifted their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. UBS Group began coverage on Option Care Health in a research report on Thursday, December 5th. They set a "neutral" rating and a $26.00 target price on the stock. Finally, Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $33.00.
Read Our Latest Stock Analysis on Option Care Health
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
